Back to Search
Start Over
Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome
- Source :
- Blood Advances; November 2023, Vol. 7 Issue: 21 p6532-6539, 8p
- Publication Year :
- 2023
-
Abstract
- •Treatment outcomes for relapsed or refractory ML-DS remain dismal in a contemporary treatment period (3-year OS 22%).•Patients who had a long duration of first remission, achieved a second remission and underwent HSCT were most likely to survive.
Details
- Language :
- English
- ISSN :
- 24739529 and 24739537
- Volume :
- 7
- Issue :
- 21
- Database :
- Supplemental Index
- Journal :
- Blood Advances
- Publication Type :
- Periodical
- Accession number :
- ejs62193201
- Full Text :
- https://doi.org/10.1182/bloodadvances.2022009381